• Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-07-13

  Gu et al. (2025) demonstrate that combined CDK4/6 and BET inhibition synergistically suppresses pancreatic ductal adenocarcinoma growth and reverses pro-metastatic phenotypes by modulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight supports rational combination strategies for overcoming therapeutic resistance in pancreatic cancer.

• a-MSH, amide: Innovating Translational Pigmentation Research

  2026-07-13

  This thought-leadership article provides mechanistic insight and strategic guidance for translational researchers using a-MSH, amide in pigmentation regulation and anti-inflammatory studies. Integrating recent evidence on melanogenesis modulation, it contextualizes APExBIO’s a-MSH, amide within the evolving landscape, highlights protocol best practices, and charts a visionary path for translational impact.

• Live-Dead Cell Staining Kit: Precision Cell Viability in Act

  2026-07-12

  Unlock rigorous, quantitative live/dead cell analysis across cytotoxicity, biomaterial, and wound-healing research. The Live-Dead Cell Staining Kit leverages dual-dye discrimination for unmatched accuracy in both microscopy and flow cytometry workflows.

• ATRX Deficiency Sensitizes Glioma Cells to RTK and PDGFR Inh

  2026-07-10

  This study reveals that high-grade glioma cells lacking ATRX are significantly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. These findings highlight the importance of considering ATRX mutation status when designing targeted therapeutic strategies and analyzing clinical trial outcomes in glioma.

• Quercetin Shields Cataract Lenses by Modulating Hippo Pathwa

  2026-07-09

  The referenced study uncovers how quercetin exerts protective effects against cataract formation by downregulating the Hippo signaling pathway, thereby enhancing epithelial cell survival and reducing oxidative stress. These findings provide mechanistic insight for non-surgical cataract interventions and highlight the potential for pathway-targeted therapies.

• Phosphoenolpyruvate Restricts cGAS-STING Inflammation in Agi

  2026-07-09

  The referenced study uncovers a conserved, adaptive role for the glycolytic metabolite phosphoenolpyruvate (PEP) in repressing cGAS-STING-mediated inflammation during aging. These findings provide a mechanistic basis for targeting metabolic signaling to promote healthy aging and suggest new avenues for metabolic probe use in inflammation and energy homeostasis research.

• Carbapenemase Genes and Resistance Spread in CREC: A 2022–20

  2026-07-08

  This study offers a detailed analysis of carbapenemase-encoding gene (CEG) prevalence and transmission dynamics in carbapenem-resistant Enterobacter cloacae (CREC) from hospitals in Guangdong, China during and after the COVID-19 pandemic. By integrating genotypic, epidemiological, and antimicrobial susceptibility data, the work advances our understanding of multidrug resistance mechanisms and horizontal gene transfer in clinical Enterobacter isolates.

• Miltefosine in Hematology: PI3K/Akt Inhibition and Neutrophi

  2026-07-08

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) bridges targeted PI3K/Akt inhibition with Ras/MEK/ERK-driven neutrophil differentiation, offering a dual-mechanism tool for leukopenia and cancer research. This article delivers actionable protocols, troubleshooting, and insight into Miltefosine’s unique value for experimental hematology and immune recovery.

• Bacterial OMV-Based mRNA Antigen Display for Personalized Tu

  2026-07-07

  Li et al. present a genetically engineered bacterial outer membrane vesicle (OMV) system for rapid and efficient surface display of mRNA antigens, enabling a novel personalized tumor vaccine strategy. This platform bypasses the limitations of lipid nanoparticles, offering both rapid antigen customization and intrinsic immune stimulation, and demonstrates significant antitumor efficacy and immune memory in preclinical models.

• Linezolid in Translational Research: Mechanisms and Strategy

  2026-07-07

  This article offers a thought-leadership perspective on deploying Linezolid, an oxazolidinone antimicrobial, as a strategic tool in translational research. By integrating mechanistic insight, experimental guidance, and competitive context, it empowers researchers to optimize workflows targeting multidrug-resistant Gram-positive pathogens—including MRSA and VRE—while highlighting the evolving landscape of antibacterial innovation and the benchmark role of APExBIO’s Linezolid.

• Inducing Right Ventricular Cardiomyocytes from Human PSCs

  2026-07-06

  Saito et al. present a robust protocol to generate right ventricular-like cardiomyocytes from human pluripotent stem cells, addressing a key bottleneck for chamber-specific cardiac disease models. These findings enable more precise in vitro studies of RV pathophysiology and drug response, supporting translational cardiac research.

• Aligned Silk Fibroin–Ce6 Films Enable Photodynamic Antibacte

  2026-07-06

  This study introduces an anisotropic silk fibroin film functionalized with Chlorin e6 (Ce6) to create a bioscaffold capable of rapid, light-triggered antibacterial action against S. aureus. The engineered material not only eradicates infection via ROS generation but also promotes wound healing by modulating macrophage polarization, establishing a dual-function approach for advanced tissue repair.

• Hybrid Thermosensitive Hydrogel Boosts Ocular Erythromycin D

  2026-07-05

  This study presents a thermosensitive polyhedral oligomeric silsesquioxane hybrid hydrogel (BPEP) that significantly enhances the ocular delivery and antibacterial efficacy of erythromycin in a mouse model of bacterial keratitis. The innovative hydrogel overcomes solubility and residence time limitations, demonstrating improved therapeutic outcomes and biocompatibility.

• BAY-826: Potent Small Molecule Inhibitor for Retinal Assays

  2026-07-04

  BAY-826 empowers precision in dissecting angiopoietin and PEDF signaling, offering unmatched selectivity for retinal neuron survival studies. Its robust potency and workflow adaptability make it the trusted tool for neurovascular research, as validated by recent mechanistic breakthroughs.

• WM-8014: Precision KAT6A Inhibitor for Epigenetic Research

  2026-07-03

  WM-8014 stands at the forefront of selective KAT6A inhibition, enabling robust cell cycle arrest and oncogene-induced senescence assays with minimal off-target effects. Its nanomolar potency and reversible, competitive mechanism make it an indispensable tool for dissecting epigenetic drug targets and resistance pathways in cancer biology.

15345 records 1/1023 page Next 12345 下5页 Last page